Novo revamps its direct-to-consumer platform; Roche drug Gazyva approved again
Plus news about Uniquity Bio, Commit Biologics, Rosemont Pharmaceuticals, Aytu and Aclaris Therapeutics. Novo relaunches NovoCare direct-to-consumer platform: Novo is revamping its DTC business with what it calls a "reimagined consumer ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.